New sensor could help doctors drain fluid from heart failure Patients' lungs

NCT ID NCT07600398

Ongoing Disease control Sponsor: Instituto Cardiovascular de Buenos Aires Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a wearable sensor that measures lung fluid can help doctors better treat fluid buildup in patients hospitalized for acute heart failure. About 216 adults will be randomly assigned to either standard care or care guided by the sensor. The goal is to see if the sensor-guided approach reduces the risk of death, rehospitalization, or urgent heart failure visits within 30 days after discharge.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Remote Dielectric Sensing (ReDS) device
What this could lead to: If it works, this could give doctors a simple, non-invasive tool to better manage fluid levels in heart failure patients, potentially reducing hospital readmissions.
What could go wrong: This is a relatively small, early-stage trial (216 participants) testing a device, not a drug. The benefit may be modest or not statistically significant, and results may not apply to all heart failure patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE HEART FAILURE (AHF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE HEART FAILURE (AHF)

Contacts and locations

Locations

Instituto Cardiovascular de Buenos Aires

Buenos Aires, Buenos Aires, 1428, Argentina

More trials for these conditions

Other studies related to the condition(s) this trial covers.